A Food and Drug Administration analysis of survival outcomes comparing the Adjuvant Paclitaxel and Trastuzumab trial with an external control from historical clinical trials
Laleh Amiri‐Kordestani, Diqiong Xie, Sara M. Tolaney, Erik Bloomquist, Shenghui Tang, Amna Ibrahim, Kirsten B. Goldberg, Marc R. Theoret, Richard Pazdur, R. Sridhara, Eric P. Winer, Julia A. Beaver
Topics & Concepts
MedicineTrastuzumabTaxaneOncologyInternal medicineBreast cancerClinical trialCarboplatinMetastatic breast cancerRandomized controlled trialAnthracyclineCancerSurgeryChemotherapyCisplatinBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Treatment and Pharmacology